Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystic Fibrosis | 20 | 2024 | 1274 | 4.000 |
Why?
|
Systemic Inflammatory Response Syndrome | 14 | 2024 | 621 | 2.900 |
Why?
|
Myocarditis | 3 | 2023 | 766 | 1.470 |
Why?
|
Lung Diseases | 4 | 2020 | 1915 | 1.240 |
Why?
|
Pseudomonas aeruginosa | 9 | 2024 | 1275 | 1.210 |
Why?
|
Neutrophils | 9 | 2022 | 3770 | 1.200 |
Why?
|
Respiratory Mucosa | 3 | 2024 | 441 | 1.090 |
Why?
|
Transendothelial and Transepithelial Migration | 4 | 2017 | 103 | 0.950 |
Why?
|
Antibodies, Viral | 12 | 2024 | 3145 | 0.830 |
Why?
|
Pseudomonas Infections | 4 | 2024 | 623 | 0.800 |
Why?
|
Connective Tissue Diseases | 2 | 2023 | 286 | 0.790 |
Why?
|
Lung Transplantation | 2 | 2020 | 1304 | 0.730 |
Why?
|
Haptoglobins | 1 | 2021 | 167 | 0.700 |
Why?
|
Endocannabinoids | 1 | 2021 | 111 | 0.700 |
Why?
|
Child | 35 | 2024 | 79758 | 0.670 |
Why?
|
Eicosanoids | 1 | 2021 | 278 | 0.650 |
Why?
|
Specimen Handling | 2 | 2020 | 708 | 0.640 |
Why?
|
Glycogen Storage Disease | 1 | 2018 | 41 | 0.640 |
Why?
|
Coculture Techniques | 4 | 2022 | 1340 | 0.610 |
Why?
|
Antigens, Human Platelet | 1 | 2017 | 41 | 0.580 |
Why?
|
Referral and Consultation | 2 | 2020 | 3598 | 0.570 |
Why?
|
Protein Precursors | 1 | 2021 | 1135 | 0.570 |
Why?
|
Advance Directives | 1 | 2018 | 248 | 0.550 |
Why?
|
Viral Load | 3 | 2021 | 3323 | 0.530 |
Why?
|
Adaptive Immunity | 3 | 2021 | 724 | 0.510 |
Why?
|
Patient Preference | 2 | 2020 | 921 | 0.470 |
Why?
|
DNA Transposable Elements | 1 | 2018 | 752 | 0.470 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3086 | 0.460 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3206 | 0.460 |
Why?
|
Mutagenesis | 1 | 2018 | 1234 | 0.460 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 4 | 2024 | 446 | 0.450 |
Why?
|
Palliative Care | 4 | 2024 | 3607 | 0.430 |
Why?
|
8,11,14-Eicosatrienoic Acid | 3 | 2017 | 64 | 0.420 |
Why?
|
Pregnancy Complications, Infectious | 5 | 2022 | 2127 | 0.410 |
Why?
|
Bronchoscopes | 1 | 2012 | 64 | 0.400 |
Why?
|
Humans | 79 | 2024 | 760261 | 0.400 |
Why?
|
Leukotriene B4 | 3 | 2017 | 281 | 0.380 |
Why?
|
Advance Care Planning | 1 | 2018 | 697 | 0.370 |
Why?
|
Pulmonary Aspergillosis | 1 | 2011 | 47 | 0.370 |
Why?
|
Respiratory Insufficiency | 1 | 2019 | 1228 | 0.370 |
Why?
|
Bronchoscopy | 2 | 2018 | 908 | 0.370 |
Why?
|
Infant | 12 | 2024 | 36030 | 0.360 |
Why?
|
Child, Preschool | 12 | 2024 | 42034 | 0.360 |
Why?
|
Respiratory System Abnormalities | 1 | 2011 | 67 | 0.360 |
Why?
|
Fiber Optic Technology | 1 | 2012 | 289 | 0.350 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3023 | 0.350 |
Why?
|
Pandemics | 9 | 2023 | 8621 | 0.350 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1663 | 0.340 |
Why?
|
Lung Diseases, Interstitial | 1 | 2018 | 907 | 0.340 |
Why?
|
Immunity, Humoral | 2 | 2024 | 604 | 0.330 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1570 | 0.320 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1634 | 0.320 |
Why?
|
Lung | 5 | 2022 | 9989 | 0.320 |
Why?
|
Airway Management | 1 | 2012 | 310 | 0.310 |
Why?
|
Monocytes | 3 | 2022 | 2574 | 0.310 |
Why?
|
Infant, Newborn | 12 | 2022 | 26168 | 0.300 |
Why?
|
Antibody Formation | 2 | 2022 | 1400 | 0.300 |
Why?
|
Inflammation | 8 | 2022 | 10757 | 0.300 |
Why?
|
Quality of Life | 4 | 2024 | 13300 | 0.290 |
Why?
|
Respiratory Tract Infections | 1 | 2015 | 1001 | 0.280 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3242 | 0.280 |
Why?
|
Genetic Testing | 1 | 2020 | 3530 | 0.280 |
Why?
|
Young Adult | 12 | 2024 | 58673 | 0.280 |
Why?
|
Adolescent | 16 | 2023 | 87747 | 0.270 |
Why?
|
Terminal Care | 1 | 2018 | 1759 | 0.270 |
Why?
|
Neutrophil Infiltration | 3 | 2017 | 394 | 0.270 |
Why?
|
Staphylococcus aureus | 3 | 2024 | 1462 | 0.270 |
Why?
|
Benzodioxoles | 2 | 2023 | 75 | 0.270 |
Why?
|
Aminophenols | 2 | 2023 | 86 | 0.260 |
Why?
|
Tomography, Optical Coherence | 4 | 2021 | 2878 | 0.260 |
Why?
|
Vaccination | 5 | 2024 | 3360 | 0.260 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 3967 | 0.250 |
Why?
|
Placenta | 4 | 2022 | 1701 | 0.240 |
Why?
|
Phenazines | 1 | 2024 | 56 | 0.240 |
Why?
|
Immunoglobulin G | 5 | 2023 | 4546 | 0.230 |
Why?
|
Hyperglycemia | 2 | 2024 | 1380 | 0.230 |
Why?
|
Massachusetts | 3 | 2022 | 8805 | 0.230 |
Why?
|
Epithelium | 2 | 2019 | 1605 | 0.220 |
Why?
|
Epithelial Cells | 3 | 2022 | 3665 | 0.220 |
Why?
|
Opiate Alkaloids | 1 | 2023 | 28 | 0.210 |
Why?
|
Cell Movement | 3 | 2021 | 5206 | 0.210 |
Why?
|
Immunity | 4 | 2022 | 998 | 0.210 |
Why?
|
Microbial Sensitivity Tests | 3 | 2024 | 1952 | 0.210 |
Why?
|
Health Promotion | 1 | 2015 | 2208 | 0.210 |
Why?
|
Immunoglobulin A | 2 | 2023 | 978 | 0.200 |
Why?
|
Primary Health Care | 1 | 2019 | 4649 | 0.200 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5644 | 0.190 |
Why?
|
Anti-Bacterial Agents | 5 | 2024 | 7400 | 0.180 |
Why?
|
Complementarity Determining Regions | 1 | 2021 | 149 | 0.180 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 111 | 0.180 |
Why?
|
Quinolones | 1 | 2023 | 377 | 0.170 |
Why?
|
Chemotaxis, Leukocyte | 3 | 2017 | 663 | 0.170 |
Why?
|
Lymphopenia | 1 | 2022 | 280 | 0.170 |
Why?
|
Pepsin A | 1 | 2019 | 66 | 0.170 |
Why?
|
Bile | 1 | 2020 | 296 | 0.170 |
Why?
|
Adult | 21 | 2024 | 219847 | 0.170 |
Why?
|
Gastric Acid | 1 | 2019 | 98 | 0.170 |
Why?
|
DNA | 1 | 2013 | 7236 | 0.170 |
Why?
|
Permeability | 1 | 2021 | 719 | 0.170 |
Why?
|
Forced Expiratory Volume | 2 | 2023 | 1810 | 0.160 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5793 | 0.160 |
Why?
|
Aspergillus fumigatus | 1 | 2020 | 156 | 0.160 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 463 | 0.160 |
Why?
|
Female | 29 | 2024 | 391011 | 0.150 |
Why?
|
Cytokines | 2 | 2023 | 7345 | 0.150 |
Why?
|
Aspergillosis | 1 | 2020 | 243 | 0.150 |
Why?
|
Candida albicans | 1 | 2021 | 378 | 0.150 |
Why?
|
Tobramycin | 1 | 2017 | 67 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 801 | 0.150 |
Why?
|
Antigens, Viral | 1 | 2021 | 980 | 0.140 |
Why?
|
Fumarates | 1 | 2017 | 131 | 0.140 |
Why?
|
Bacteria | 2 | 2020 | 2196 | 0.140 |
Why?
|
New England | 1 | 2020 | 1045 | 0.140 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2021 | 1349 | 0.140 |
Why?
|
Cell Wall | 1 | 2020 | 425 | 0.140 |
Why?
|
Pediatrics | 3 | 2020 | 3587 | 0.140 |
Why?
|
Virus Internalization | 1 | 2020 | 494 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17766 | 0.140 |
Why?
|
RNA, Messenger | 4 | 2024 | 12762 | 0.140 |
Why?
|
Cell Line | 4 | 2019 | 15626 | 0.140 |
Why?
|
Male | 20 | 2024 | 359413 | 0.130 |
Why?
|
Drug Resistance, Bacterial | 2 | 2020 | 1054 | 0.130 |
Why?
|
Pulmonary Alveoli | 1 | 2018 | 653 | 0.130 |
Why?
|
Oligopeptides | 1 | 2021 | 1188 | 0.130 |
Why?
|
Age Factors | 2 | 2024 | 18415 | 0.130 |
Why?
|
Nose | 1 | 2019 | 519 | 0.130 |
Why?
|
Mutagenesis, Insertional | 1 | 2018 | 652 | 0.130 |
Why?
|
Indoles | 1 | 2023 | 1830 | 0.120 |
Why?
|
Phagocytosis | 1 | 2021 | 1536 | 0.120 |
Why?
|
Fetal Development | 1 | 2020 | 765 | 0.120 |
Why?
|
Staphylococcal Infections | 1 | 2024 | 1405 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1354 | 0.120 |
Why?
|
Chemotaxis | 1 | 2017 | 598 | 0.120 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2021 | 807 | 0.120 |
Why?
|
Cytosol | 1 | 2017 | 887 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 22066 | 0.120 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 926 | 0.110 |
Why?
|
Cell Polarity | 1 | 2017 | 638 | 0.110 |
Why?
|
Autoantibodies | 1 | 2023 | 2119 | 0.110 |
Why?
|
Fetal Blood | 1 | 2020 | 1343 | 0.110 |
Why?
|
Peroxidase | 1 | 2017 | 604 | 0.110 |
Why?
|
Transcription Factors | 1 | 2013 | 12100 | 0.110 |
Why?
|
Autoimmunity | 1 | 2021 | 1370 | 0.110 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2473 | 0.110 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25928 | 0.100 |
Why?
|
Bacterial Proteins | 3 | 2024 | 3822 | 0.100 |
Why?
|
Acute Disease | 1 | 2023 | 7268 | 0.100 |
Why?
|
Rhinitis | 1 | 2020 | 747 | 0.100 |
Why?
|
Nanoparticles | 1 | 2024 | 1938 | 0.100 |
Why?
|
Biofilms | 3 | 2024 | 622 | 0.100 |
Why?
|
Cost of Illness | 2 | 2023 | 1940 | 0.100 |
Why?
|
Immunity, Innate | 2 | 2022 | 3046 | 0.100 |
Why?
|
Patient Participation | 1 | 2020 | 1437 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1799 | 0.090 |
Why?
|
Case-Control Studies | 4 | 2021 | 22041 | 0.090 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 2628 | 0.090 |
Why?
|
Sinusitis | 1 | 2020 | 992 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15827 | 0.090 |
Why?
|
Mutation | 2 | 2023 | 29950 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3106 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2021 | 2730 | 0.090 |
Why?
|
Cell Communication | 1 | 2017 | 1642 | 0.090 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2024 | 457 | 0.080 |
Why?
|
Lactation | 2 | 2022 | 395 | 0.080 |
Why?
|
Pregnancy | 8 | 2022 | 29725 | 0.080 |
Why?
|
Depression | 2 | 2019 | 8033 | 0.080 |
Why?
|
Influenza A virus | 2 | 2022 | 457 | 0.070 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10183 | 0.070 |
Why?
|
Membrane Transport Proteins | 2 | 2024 | 1036 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3223 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4370 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6775 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4044 | 0.070 |
Why?
|
Comorbidity | 1 | 2020 | 10552 | 0.060 |
Why?
|
Pilot Projects | 1 | 2019 | 8553 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5884 | 0.060 |
Why?
|
Virulence | 2 | 2020 | 1295 | 0.060 |
Why?
|
Sexual Behavior | 1 | 2015 | 2080 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3206 | 0.060 |
Why?
|
Animals | 5 | 2021 | 167940 | 0.060 |
Why?
|
Pyocyanine | 1 | 2024 | 20 | 0.060 |
Why?
|
Asthma | 1 | 2023 | 6167 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3520 | 0.060 |
Why?
|
Tetracycline | 1 | 2024 | 224 | 0.060 |
Why?
|
Carboxylic Acids | 1 | 2024 | 90 | 0.060 |
Why?
|
RNA, Viral | 2 | 2023 | 2837 | 0.060 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2024 | 105 | 0.060 |
Why?
|
Health Behavior | 1 | 2015 | 2621 | 0.050 |
Why?
|
Sulfates | 1 | 2024 | 379 | 0.050 |
Why?
|
Conscious Sedation | 1 | 2007 | 529 | 0.050 |
Why?
|
Retinopathy of Prematurity | 1 | 2007 | 432 | 0.050 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 1933 | 0.050 |
Why?
|
Alginates | 1 | 2024 | 247 | 0.050 |
Why?
|
United States | 4 | 2023 | 72363 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4532 | 0.050 |
Why?
|
Cohort Studies | 5 | 2023 | 41317 | 0.050 |
Why?
|
Fomites | 1 | 2021 | 15 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8641 | 0.050 |
Why?
|
Polysaccharides, Bacterial | 1 | 2024 | 574 | 0.050 |
Why?
|
Neutrophil Activation | 1 | 2021 | 181 | 0.050 |
Why?
|
Nasal Lavage | 1 | 2020 | 17 | 0.050 |
Why?
|
Communication | 1 | 2015 | 3846 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10761 | 0.040 |
Why?
|
Laser Therapy | 1 | 2007 | 1089 | 0.040 |
Why?
|
Naphthols | 1 | 2020 | 46 | 0.040 |
Why?
|
Chlorides | 1 | 2023 | 666 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 131 | 0.040 |
Why?
|
Spirometry | 1 | 2023 | 924 | 0.040 |
Why?
|
Spores, Fungal | 1 | 2020 | 90 | 0.040 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2024 | 586 | 0.040 |
Why?
|
Mucociliary Clearance | 1 | 2019 | 80 | 0.040 |
Why?
|
Ebolavirus | 1 | 2022 | 252 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 534 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2021 | 545 | 0.040 |
Why?
|
Middle Aged | 4 | 2024 | 220175 | 0.040 |
Why?
|
Blood Glucose | 2 | 2024 | 6375 | 0.040 |
Why?
|
Aerosols | 1 | 2021 | 633 | 0.040 |
Why?
|
Esophageal pH Monitoring | 1 | 2019 | 201 | 0.040 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2024 | 1129 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 582 | 0.040 |
Why?
|
Perinatal Care | 1 | 2020 | 240 | 0.040 |
Why?
|
Quinolines | 1 | 2023 | 759 | 0.040 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 221 | 0.040 |
Why?
|
Melanins | 1 | 2020 | 291 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12281 | 0.040 |
Why?
|
Needs Assessment | 1 | 2023 | 1137 | 0.040 |
Why?
|
Mucus | 1 | 2019 | 338 | 0.040 |
Why?
|
Drug Combinations | 1 | 2023 | 2024 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2020 | 565 | 0.040 |
Why?
|
Species Specificity | 1 | 2022 | 2413 | 0.040 |
Why?
|
Granulocytes | 1 | 2019 | 551 | 0.040 |
Why?
|
Bile Acids and Salts | 1 | 2019 | 380 | 0.040 |
Why?
|
Risk Factors | 1 | 2024 | 74269 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6855 | 0.040 |
Why?
|
Carrier State | 1 | 2021 | 525 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2022 | 821 | 0.030 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 537 | 0.030 |
Why?
|
Azithromycin | 1 | 2017 | 201 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13505 | 0.030 |
Why?
|
Mice | 3 | 2017 | 81216 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1529 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2023 | 1399 | 0.030 |
Why?
|
Outpatients | 1 | 2023 | 1606 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1021 | 0.030 |
Why?
|
Sputum | 1 | 2017 | 503 | 0.030 |
Why?
|
Cilia | 1 | 2019 | 492 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2509 | 0.030 |
Why?
|
Receptors, Leukotriene B4 | 1 | 2014 | 92 | 0.030 |
Why?
|
Psychometrics | 1 | 2024 | 3049 | 0.030 |
Why?
|
Viral Proteins | 1 | 2022 | 1802 | 0.030 |
Why?
|
Intestine, Small | 1 | 2020 | 1207 | 0.030 |
Why?
|
Proton Pump Inhibitors | 1 | 2019 | 551 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54263 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3302 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2022 | 1811 | 0.030 |
Why?
|
Patient Care Management | 1 | 2017 | 303 | 0.030 |
Why?
|
Infection Control | 1 | 2021 | 983 | 0.030 |
Why?
|
Models, Organizational | 1 | 2017 | 545 | 0.030 |
Why?
|
Esophagus | 1 | 2019 | 1023 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58947 | 0.030 |
Why?
|
Pyrazoles | 1 | 2023 | 1992 | 0.030 |
Why?
|
Otolaryngology | 1 | 2020 | 685 | 0.030 |
Why?
|
Aged | 3 | 2021 | 168995 | 0.030 |
Why?
|
Gastroesophageal Reflux | 1 | 2019 | 816 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2441 | 0.020 |
Why?
|
Pyridines | 1 | 2023 | 2877 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 3061 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3096 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2014 | 731 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1617 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5039 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 12412 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2022 | 4739 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4276 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20484 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3810 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6499 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14482 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2014 | 1402 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20048 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9388 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9283 | 0.020 |
Why?
|
Smoking | 1 | 2021 | 9070 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16905 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18968 | 0.010 |
Why?
|
Time Factors | 1 | 2022 | 40133 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 2007 | 1328 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22025 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2007 | 2623 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18134 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 80301 | 0.010 |
Why?
|